The aim of the present paper was to investigate the role of circulating methylated RASSF1A as a non-invasive marker in melanoma patients and to compare RASSF1A methylation status in cfDNA with the presence of CTCs identified by two different methods (isolation of CTCs by size and quantification of tyrosinase mRNA by RT-qPCR). This evidence concerns the gene TYR and melanoma.